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0.0 SUMMARY 
Title : Cryptorchidism 
Cryptorchidism is the most common congenital urogenital anomaly seen in male children. The 
incidence of cryptorchidism varies from 2-4 % in the male infant population and is more 
common in premature infants. Mechanisms involved in the etiology of this pathology require an 
understanding of the underlying embryology of testicular descent. The process of testicular 
decent has been clearly established to occur in two phases: the intra-abdominal phase and the 
inguino-scrotal phase. Both are regulated by complex hormonal and genetic factors, among 
which a balance between androgens and estrogens seems to play an important role. 
Environmental factors like estrogen disrupters have been incriminated in etiology of 
cryptorchidism, but their precise role has not yet been clearly established.  
Most cryptorchid testis diagnosed at birth will eventually achieve descent by the first three 
months after birth. Diagnosis of cryptorchidism relies on patient genital examination. A 
functional classification of palpable or impalpable testis provides the first step in the diagnostic 
and therapeutic algorithm. While radiological investigation such as ultrasound and computed 
tomography are of no use in the diagnosis of impalpable testis, laparoscopic exploration provides 
the most accurate diagnostic method in assessment and localization of impalpable testis. 
Laparoscopy is ultimately also used in the treatment of cryptorchidism. The current standard 
therapeutic option relies on surgical repositioning of the gonad within the scrotum. Hormonal 
treatment is of little value but can be used as an adjuvant therapy to improve fertility rather than 
stimulating testicular descent. Orchidopexy should be performed by 18 months of age in order to 
preserve testicular function and decrease risk for malignancy. 
Key words : undescended testis , gubernaculum , infertility , testicular cancer 
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1.0 INTRODUCTION 
Cryptorchidism comes from the greek word cryptos which means hidden and orchis  
which means testis, and occurs when one or both testis fail to achieve complete decent into the 
scrotum. This developmental abnormality is the most common urogenital malformation seen in 
male children. The defect can occur as a single entity  or can also be associated with multi 
systemic syndromes. Underlying mechanisms involved in the etiology of cryptorchidism 
intertwine hormonal, genetic and environmental factors. The ability of a clinician to detect the 
defect in early childhood provides the future male patient with a better long term reproductive 
outcome. 
 
2.0 EMBRYOLOGY OF TESTICULAR DEVELOPMENT AND DESCENT 
The development of the gonads and genital duct system begins approximately around the 
fifth week of gestation.(1) At this time, the human undifferentiated gonads develop adjacent to 
the ventro-medial side of the mesonephros. Below, we discuss the two major phases in which 
testicular descent is sequentially divided into.(2) 
 
2.1 The intra abdominal phase 
The intra-abdominal phase starts with inguinal canal development . This canal forms the pathway 
for the testis to descend though the abdominal wall into the scrotum. As the mesonephron 
degenerates, the gubernaculum descends on each side from the lower pole of the gonads and 
attaches to the future scrotum. (3) 
2 
 
Later on , by the 12 th week of gestation , the processus vaginalis  (peritoneal sac) develops 
along the ventral side of the lower gubernaculum and herniates though the lower abdominal wall 
along the pouch form by the gubernaculum. 
Each processus vaginalis carries extensions of layers of the abdominal wall before it and 
together they form the covering wall of the inguinal canal and future covering of the testis and 
spermatic cords. 
 
   2.2 The inguino-scrotal phase 
Once the canal is created, the testis will start their migration though the inguinal canal, 
this occurs at around week 28, and the process then takes approximately two to three days. The 
testis moves beneath the peritoneum and behind the processus vaginalis. 
The testes then reach the orifice of the inguinal canal around the sixth month of gestation, 
then cross the canal during the seventh month and finally reach their definitive intrascrotal 
position at the end of the eighth month of gestation. 
 
 2.3 Testis development 
The human gonad cell formation within the testis relies on the expression of the SRY 
(sex determining region Y) and other genes like SOX9, expressed between days 41 and 44. Their 
expression trigger sertoli and testicular cord formation by the ninth week of gestation: (3) 
Sertoli cells functions include: 
regulation of spermatogenesis though endocrine folicular stimulating hormone (FSH) and 
testosterone 
regulation of the intra-tubular and intercellular environment 
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sequestration of meiotic and post-meiotic germ cells 
production of anti-mullerian hormone (AMH) causing regression of mullerian ducts between 
weeks 9 and 10. 
 
Leydig cell development is divided into three phases: a proliferation and differentiation 
phase between 7 and 14 weeks of gestation, a maturation phase until 18 week of gestation and 
finally an involution phase that continues until term. Leydig cells start secreting testosterone as 
early as 6 to 7 weeks but appear to be at first independent to gonadotrophin stimulation. Insulin-
like 3 (INS-3) of leydig cells is measurable in human amniotic fluid by the 13 week. Evidence 
from animal models suggests that INS-3 and testosterone are keys hormones required for 
testicular descent. 
 
   2.4 Regulation of testicular descent 
Testicular descent is a complex embryological process. Many reviews of testicular 
descent by researchers emphasize the importance of both hormonal and genetic involvement in 
testicular decent.(5) For example, take INS-3, it is secreted by the leydig cells and causes the 
gubernaculum to swell. This swelling reaction does not only dilate the inguinal canal but also 
holds the testis near the groin as the fetal abdomen enlarges between 8 and 15 weeks of 
development. 
Hormonal regulation of the second phase of descent is clearly dependent on androgenic 
influence but a precise mechanism remains controvertial.The second phase starts at 15 weeks of 
gestation. Many studies in mice and marsupials have shown a role for the genito-femoral nerve 
in guiding and/ or promoting passage of the gubernaculums(6). It releases the neuro-transmitter 
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calcitonin gene-related peptide (CGRP) which acts on the gubernaculum receptor which 
subsequently results in mitoses and suppression of apoptosis, thus guiding the elongation of the 
gubernaculum toward the scrotum by chemotaxis.(7) In summary, testicular descent is a complex 
mechanism involving enlargement of the gubernaculum and distal detachment and migration to 
the distal detachment and migration to initiate caudal migration of the testes.  
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3.0 CLASSIFICATION OF UNDESCENDED TESTIS  
 
Undescended testes are defined as a disruption in migration of the testes along its normal 
pathway between the lumbar region and the scrotum. Normal scrotal position has been defined as 
the midpoint of the testis or below the mid-scrotum. Testis may be classified clinically as 
palpable or non palpable, in which non palpable testes can either be cryptorchid or absent. 
 
Precise classification of undecended testes: 
 
Congenital cryptorchidism: testes that are extra-scrotal at birth 
Recurrent cryptorchidism: occurs when testes are initially present in the scrotum at birth 
and subsequently return to a non-scrotal position 
Secondary cryptorchidism: applies to testes which become supra-scrotally located after 
hernial repair or as a complication of orchidopexy. 
 
It is important not to confuse undecended testes with ectopic testes. Ectopic  
 testes descend normally though the external inguinal ring but are misdirected in the subsequent 
descent to an extra-scrotal position. The most common site of ectopic testes is the superficial 
inguinal pouch between the external oblique aponeurosis and the subcutaneous tissue. Perineal, 
prepenile, transverse scrotal, femoral and abdominal positions are other less common sites of 
ectopia. Retractile testes is defined as  a possibly manipulated supra-scrotal testes that can be 
easily tract down into the scrotum. 
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Incomplete testicular descent can be described as unilateral or bilateral and the position of 
the testes may occupy an intra-abdominal, intracanalicular or supra-scrotal position. 
 
 
 
 
 3.1 Incidence and associated anomalies 
Generally, it is difficult to compare the frequency of cryptorchidism in different 
publications as the definition of cryptorchidism varies from one country to another.(8)  
Howevere it is generally accepted that 2 to 3 % of full term and 17 to 30% of premature male 
neonates have one or more testis that have not completely descended to the scrotum. In 25 % of 
patients with cryptorchidism the condition is bilateral. The frequency of undescended testes in a 
population has been shown to be dependent on birth weight. Premature boys have a significantly 
increased risk of having the defect. Incidence of the undescended testes at birth for premature 
and/or low birth weight (< 2500 g) infants varies from 1,1 to 45 %. Low birth weight is a well 
known association with cryptorchidism and may be related to placental malformation. Other 
perinatal risk factors associated with cryptorchidism include breech presentation, maternal 
diabetes. In most affected infants the testes descend during the first three months after birth or by 
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the end of the first year of life. However, after one year of age the incidence of cryptorchidism 
remains between 0,7 % and 1 % suggesting that spontaneous descent is unusual after one year of 
age. 
 
3.2 Effect of age on prevalence of cryptorchidism 
The observation that testes, thought to be completely descended at birth, may re-ascend 
to a supra-scrotal position with time was noted by Villumsen and Zachau- Christiansen in 1966. 
In their investigations, 1,6 % of boys had unilateral or bilateral ascended testes which moved 
from a normal scrotal position at birth to a higher position by the age of 3. Other researchers 
have noted the same phenomenon and have provided case reports with well-documented data.  
Later in childhood, the ascended testis can be extremely difficult to discriminate from a 
retractile testes, and in addiction the  previous scrotal position may be hard to verify.  
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4.0 PATHOPHYSIOLOGICAL HYPOTESIS 
4.1 Genetic susceptibility 
Insulin like -3 (INL-3) and its receptor leucine-rich reoeat-contaning G protein-
coupled receptor LGR-8  
 Inl 3 is expressed in Leydig cells of the testis and theca cells of the ovary. This peptide 
affects testicular descent by acting on the gubernaculum via its specific receptor leucine-rich 
reoeat-contaning G protein-coupled receptor 8 ( LGT-8) , also known as G-protein-coupled 
receptor affecting testes descent (Great ). Therefore Insl-3 and its receptor were considered the 
most likely candidates for contributing to human non syndromic cryptorchidism, since their role 
in testicular descent has been clearly established.(11,12) However, case specific DNA coding 
variants of Insl 3 and its receptors found mutations in only 1,8 % of cryptorchid patients. On the 
other hand, it was demonstrated that estrogens and some endocrine disrupters like 
diethylstilbestrol (DES) are able to suppress transcription of Ins-3 gene of leydig cells.(14-15-16) 
In this way, maternal exposure of these type of molecules during the trans-abdominal phase 
prevents gubernaculum development and would potentially lead to cryptorchidism. 
Androgen receptor (AR)  
Two androgens, namely testosterone and dihydrotestosterone (DHT) are crucial for the 
development, function, and pathologic status of male testes and male internal and external 
genitalia.(17,) Partial androgen insensitivity syndrome (AIS) is almost nearly always associated 
with cryptorchidism. This syndrome is linked to a gene mutation in the androgen receptor which 
modifies the receptors affinity for testosterone and DHT(18). Knowledge of the role of 
androgens during the two phases of testicular migration would allow us to fully understand the 
9 
 
pathophysiology of cryptorchidism. Moreover, it was surmised that the greater the number of 
mutations involving androgen receptor function, the higher the testicle was located in the 
abdomen. Some studies have focused on a single polymorphism of the androgen receptor gene 
that may lead to cryptorchidism. The gene exhibits two polymorphic sites in exon 1, 
characterized by different numbers of CAG and GGN repeats. Recent reports have shown no 
association between triplets and overall risk of cryptorchidism. However, association of certain 
polymorphism of these two triplet repetitions would be involve in some bilateral cryptorchidism. 
Estrogen receptor (ER)  
Estrogens are not classically known to have a direct role in testicular migration. 
Nevertheless, prenatal exposure to non steroidal synthetic estrogen diethylstilbestrol disturbs the 
endocrine balance and subsequently causes cryptorchidism.(19) This exposure down regulates 
Insl-3 expression in embryonic leydig cells. In humans, there are 2 genes, each coding for one 
type of estrogen receptor, either ESR1 (alpha receptor) and ESR-2 (beta receptor). Codemoth 
and al reported that ESR alpha was a major contributor to estrogen-mediated fetal testis 
dysgenesis and cryptorchidism in their E2 exposure study of E-alpha knockout mice. These 
animal studies imply that estrogens and ER may play a role in testicular descent. Several 
researchers have examined the association between the SNPs or specific estrogen receptor alpha 
(ESR1) haplotype and the risk of cryptorchidism in humans. The first results, showed that some 
polymorphisms of these genes (for exaple: AGATA in the 3' region of ESR1 gene) were 
associated with severity of cryptorchidism. (20) 
Cytogenetics anomalies 
 Prevalence of anomalies in germ cells in patients who have a history of cryptorchidism is 
about 3 to 4%. In these cases, bilateral forms are more frequent. The principal karyotypic 
10 
 
anomalies are: klinefelter syndrome (47 , XXY), Men 46 XX, inversion of chromosome Y  (46 
XY / 47 , XXY , 46 XX/46 XY etc). Other chromosomal anomalies often implying (but not 
exclusively) chromosome Y were supposed to be associated with an increase risk of 
cryptorchidism. Among them, klinefelter syndrome is the most common, with a prevalence  of 
2% in the general male population (21). Additionally, 27% of Klinefelter patients present with 
bilateral cryptorchidism. The underlying mechanism would imply a gonadic dysgenesis leading 
to leydig cell dysfunction associated with a major disturbance in sertoli cell function and a 
disruption of the meiotic process. Felix and al search for association between anomalies in 
testicular migration and micro-deletion of Y chromosome but early results show no 
pathophysiological link between these two events.(22) 
 
 4.2 Other genetic anomalies  
Anatomic studies of the genito-femoral nerve in neonate rodents identified the calcitonin 
gene  related peptide (CGRP) . Specific binding sites for CGRP have been found on developing 
cremaster muscle fibers within the gubernaculum. CGRP may stimulate gubernaculum migration 
during testicular descent by release from the genito-femoral nerve. Mutation screening of the 
coding regions and intro-exon boundaries of CGRP revealed polymorphic variants but no 
pathogenic sequence changes in the 90 selected cases of idiopathic unilateral or bilateral 
cryptorchidism. Besides, the hypothesis that androgen/estrogen ratio may be more important than 
only one hormone per se in both sexes. This ratio is controlled by aromatase enzyme. Over 
expression or hyperactivity of aromatase could lead to relative hyperestrogenic and 
hypoandrogenic state that would disrupt testicular migration. This hypothesis was confirmed in 
an animal model. In humans, studies are in the process of demonstrating an association between 
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hyperactivity of aromatase and cryptorchidism. Paradoxically, some sporadic bilateral 
cryptorchid cases have been described with an associated aromatase deficiency. These 
observations support the idea that minimal estrogen secretion is necessary for the correct process 
of testicular migration. 
HOX genes play a key role in the morphogenesis of the segmented structure along the 
primary body axis such as brachial arches, vertebrae, cranial nerves and ganglia. Satokata and al 
reported that HOX10 knockout mice showed intra-abdominal bilateral cryptorchidism.(23) The 
testes of HOX10 knockout mice showed incomplete descent into the scrotal sac, but the degree 
of mal-descent was variable. Although HOX10 knockout mice exhibit cryptorchidism, there is 
no evidence of a relationship between HOXA 10 variants and cryptorchidism in humans, since 
the polymorphism of HOXA10 exists either in control subject or in cryptorchid patient.(24) 
 
 4.3 Syndromic chryptorchidism 
Di-George syndrome (microdeletion 22p11.2), Wiedemann Beckwith, Cornelia de lange 
(gene mutation NIPB2), Prader Willy and Down Syndromes are the poly-malformative 
syndromes in which cryptorchidism may be one of the involved symptoms. Specific mechanisms 
and etiology of cryptorchidism in these different syndromes are not always understood. Bilateral, 
undescended testes can be found in Prune-Belly syndrome (PBS).(25) This syndrome consists of 
a constellation of three major findings which include the absence of abdominal musculature, 
undescended testes and abnormal urinary tract (characterised by a tortuous and dilated urethra 
and renal dysmorphism). In PBS, the undescended testicles are usually found at the level of iliac 
vessels in the peritoneum on a long mesorchium. Kaplan et al (1986) suggested a role for intra-
abdominal pressure in the process of testicular descent additionally Hutson et al believed that 
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high intra-abdominal pressure and bladder distention block descent. The fact that the PBS patient 
can have normally descended testicles despite severe abdominal wall laxity sheds some doubts 
that simply mechanical forces are responsible for cryptorchidism. Moreover, most PBS patients 
are sporadic cases and there is no illucidated mechanism of genetic involvement in the 
development of PBS. Other abdominal wall defects have been associated with an increased risk 
of cryptorchidism. (26)These include omphalocele  and gastrochisis (15 to 30 % of cases) and 
also suggest a syndromic etiology. Also, T10 to S5 spinal anomalies are also associated with an 
increased risk of cryptorchidism. For example, in spina bifida the incidence varies from 19 to 36 
% depending at which level the cord is afffected. 
 
 4.4 Mini puberty and testicular descent 
The process of spontaneous post-natal descent after congenital cryptorchidism in the first 
year of life may be due to post-natal increases in the levels of sex-hormone called, aptly named 
mini puberty.(27) This endocrine phenomenon corresponds to a gonadotrophin surge which leads 
to an elevated level of circulating testicular androgens and Insl-3. It would secondarily promote 
physiological testicular descent. This supports the hypothesis that anomalies occurring during the 
mini puberty period could be associated with some form of cryptorchidism. However results in 
mini pubertal hormone level in cryptorchidism have been contradictory. Some studies have 
suggested that lutenising hormone (LH) and testosterone levels are decreased in boys with 
cryptorchidism as compared to controls or to boys with spontaneous testicular descent while 
other studies have found no difference in hormonal level.(28) Furthermore, in some studies 
where special attention was paid to the time point of sampling, cryptorchidism was associated 
with increased mini-pubertal gonadotrophin levels and reduced inhibin B levels as compared to 
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controls (Suomi and al; 2006). However, many researchers argue that the correct run of this mini 
puberty influences fertility in patient with cryptorchidism. 
 
4.5 Dysgenesis syndrome hypothesis: Environmental exposure  
Over few decades, it was observed that a constellation of reproductive abnormalities 
including testicular cancer, hypospadias and reduced sperm count are all part of a syndrome 
called testicular dysgenesis syndrome.(29) Different arguments made the hypothesis of a 
pathophysiological link between these anomalies: compared studies made in different European 
countries showed higher incidence of hypospadia, cryptorchidism, and testicular cancer 
compared to others. Cryptorchidism is a well-known risk factor for testicular cancer. Hypospadia 
and oligospermia are also risk factor for testicular cancer. Infertile males are at increased risk for 
developing testicular cancer 
In 1993, Sharpe and Skakkeback suggested that this syndrome could be caused by some 
perturbation in the development and differentiation of the testicle during fetal life. The concern 
for a link between EDC and cryptorchidism arose due to a reported increased risk of 
cryptorchidism after maternal exposure to DES. In humans, there is data supporting a correlation 
between exposure to antiandrogenic and/or estrogenic EDC (such as pesticides, flame retardants, 
and phthalates) and the occurrence of cryptorchidism. However, these data are mostly indirect or 
suggestive.Three mechanisms have been describe to explain their deleterious actions on 
testicular functions: estrogenic activity and /or anti-androgenic modification of bio-dispondibility 
of estrogen / androgen by competitive action on sex hormone binding globulin ( SHBG) causing 
a rupture in physiological balance of steroid hormone in profit of estrogen. (30) 
 
14 
 
5.0 DIAGNOSIS 
 
Before proceeding to the physical examination, the physician must take a  general 
history, specifically inquiring about prematurity and birth weight. Clinicians should also ask 
about other potential risk factors for cryptorchidism, such as gestational diabetes of the mother 
and smoking during gestation. 
 
 5.1 Physical examination 
Examination should start with a careful examination of the boy, looking for general 
dysmorphic features whcih may point to any of the closely associated syndromes. A full 
urogenital examination should be performed, including documentation of testicular palpability, 
position, hydrocele, penile size, and urethral position. Undecended testes may be located along 
the line of normal descent between the abdomen and the scrotum or in an ectopic position that is 
commonly the superficial inguinal pouch (anterior to the rectus abdominis muscle) or more 
rarely, in the peritoneal, prepubic, femoral, peripenile perineal or contro-lateral scrotal position. 
Careful examination of these areas is needed to correctly classify a testis as palpable or non 
palpable and is a critical step that determinate further diagnosis investigation. 
The method of testicular examination varies depending on age and developmental status 
of child. Infants should be examined in the supine position with legs gently frog-legged, or 
sitting on the lap of the parent. Gentle downward pressure along the inguinal canal from the 
anterior iliac spine to the scrotum and concomitant counter palpation with the opposite hand 
helps to identify the lowest position of a palpable testes. Older children may be examined in the 
up-right position cross-legged or in a supine position. Careful examination of the groin, femoral 
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region, perineum, contralateral hemiscrotum (to detect the rare case of transverse testicular 
ectopia) and pubic areas are needed in order to correctly classify a testis as palpable or non-
palpable. The palpability of the undecended testis will determinate future surgical approach. 
Once the testis is palpated, gently grasp it with the dominant hand and continue to sweep 
the testis toward the scrotum with the other hand. In palpable testes that can be manipulated into 
the scrotum, maintain the position for 30 seconds to a a couple of minutes to fatigue the 
cremaster muscle. This will allow differentiation of retractile testes from a undecended testes. 
Release the testes, and if it remains in place it is a retractible testes. If it immediately retracts to a 
prescrotal position, it is an undecended testes. Repeated examination, patient distraction 
techniques, a warm environment and use of lubricant on the examiners hands facilitate the 
physical examination. The size and location of the normally located contra lateral gonad should 
also be noted as it may increase the ability to predict the status of the undecended testes. A 
hypoplastic hemiscrotum may imply that the testis in not present. The presence of compensatory 
hypertrophy (length greater than 2 cm in pre pubertal young boys) is highly associated with 
monorchia. However, hypertrophy of the contralateral testes, if present, is either perfectly 
sensitive or specific for the presence of vanishing testes. Therefore, because surgical exploration 
is indicated in all children with a history of nonpalpable testes, these children should be referred 
to a surgical specialist regardless of the size of the contralateral testes. 
 
 
5.2 Palpable testis  
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Infants who do not have spontaneous testicular descent by six months of corrected 
gestational age should be referred to a surgical specialist for a timeline evaluation. Testes that 
remain undescended by six months are unlikely to descend spontaneously and leave the child at a 
increased risk of infirtility in adulthood. Acquired cryptorchidism is defined by a diagnosis after 
six months and must be referred for a surgical evaluation. Prevalence of acquired cryptorchidism 
is 1 to 7%, and the peak occurs around 8 years of age. Acquired cryptorchidism is more common 
in boys with a history of proximal hypospadia which suggests a common mechanism, such as 
aberrant androgen signaling. Although spontaneous descent of acquired cryptorchidism was 
reported, the same adverse histological changes are also found in primary undecended testis. 
Given the probability for post-natal descended testes to re-ascend, pediatricians should perform a 
scrotal examination at every check up. 
 
 5.3 Non palpable testis 
All newborns with bilateral, non palpable testes must be evaluated for possible disorders 
of sex development (DSD). A newborn with a male phallus and bilateral non-palpable gonad is 
potentially a genetic female (46 XX) with congenital adrenal hyperplasia until proven otherwise. 
Thus, serum electrolytes, karyotype and hormonal levels of LH, FSH, testosterone and 
androstenedionel must be obtained with simultaneous consultation with a pediatric 
endocrinologist. If the infant with bilateral non palpable testes has normal penile development or 
micropenis and a 46 YX karyotype an evaluation to distinguish between vanishing testes 
syndrome from bilateral abdominal testes should be done. To avoid surgical exploration of males 
with anorchia tests are used to assess the presence of any viable testicular tissue and include; 
MIS, inhibine B, FSH, LH and testosterone. 
17 
 
 
5.4 Radiological tests 
Given the low cost and wide availability of ultrasound it ihas the potential to contribute to 
diagnosis through ease of routine use, however with a low sensitivity and specificity to localize 
non-palpable testis it is generally not considered reliable. MRI has been more widely used in the 
USA, but given that it is expensive and not always available, is not recommended in the 
diagnosis of cryptorchidism.(31) At this time, there are no radiological tests that could conclude 
with 100%  reliability that a testis is absent. Therefore, surgical laparoscopy remains the gold 
standard diagnositic test for non palpable testis. 
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6.0 TREATMENT 
Correction of cryptorchidism is indicated to optimize testicular function , potentially 
reduce or facilitate diagnosis of testicular malignancy , provide cosmetic benefits and prevents 
complications such as clinical hernia or torsion. Except in certains cases of associated complex 
medical illness or in the post-natal period , treatment should proceed after confirmation of 
diagnosis. 
 
 6.1 Hormonal therapy 
Hormonal therapy has been used for many years for a variety of indications in patients 
with cryptorchidism, including differentiation of retractile testis from true undecendede testis, 
stimulation of testicular descent or germ cell maturation and as an adjuvant to abdominal 
orchidopexy. The latest guideline from the American urology association states that hormonal 
therapy should not be use to induce testicular descent.  
HCG or LHRH administration stimulate production of androgens by the leydig cells. The exact 
mechanism of action of increase androgen in stimulating testicular descent is not known but may 
involve an effect on testicular cords or cremaster muscle. HCG is administered by intra-muscular 
injection (IM), while GnRH can be administered intra-nasally. Despite multiple studies being 
published in regards to gormonal therapy in cryptorchidism, there are too many differences in the 
including criteria (patient age, treatment time line, and follow up times). This means that these 
studies have failed to show uniform results, but tend to demonstrate a significant risk in 
recurrence. (32,33) 
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6.2 Studies on HCG and/or its analogue to induce testis descent  
Few studies have examined the optimal dosing regimens of hormonal treatment to induce 
testicular descent.(35) Results show no difference in successful descent to the scrotum with 
different doses. Side effects of HCG treatment were seen in up to 75% of boys, including 
increase scrotal rugae, pigmentation, growth of pubic hair and penis, which may regress after 
treatment cessation. A total dose of more than 15000 IU of HCG must be avoided since it may 
induce epiphyseal plate fusion and retard future somatic growth. HCG has also been reported to 
cause a temporary increase in intra-testicular pressure and to render the testes hyperemic and 
enlarged. 
 
6.3 Studies of LHRH and/or analogs to induce testis descent 
Agonist analogs of LHRH, such as Nafarelin or Buserelin, stimulate the release of the 
pituitary gonadotrophins LH and FSH and subsequently result in a temporary increase of gonadal 
steroidogenesis. Trials comparing LHRH treatment to placebo showed that LHRH had a slightly 
higher rate of testicular descent compared to the placebo sample, but the statistical significance 
of these results was not proven (36). Once again care must be taken when using this hormonal 
therapu as the recognized side effects of GnRH include increase penile and testicular size, scrotal 
erythema or erection. However, side effects were less common than in the HCG trial. 
 
6.4 Use of hormones to improve fertility ( rather than to induce testicular descent): 
A patient born with undecended testis shows a decreased number of spermatogonia in 
their testes compared to normal boys. In some cases, histological biopsy after surgical treatment 
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does not show any germ cell presence. LHRH or HCG treatment prior to surgery was shown to 
improve fertility index in some trials, but could not be of any help in a  patient lacking germ cells 
at time of biopsy.(37) In a separate prospective study, 42 boys with 63 undecended testis, were 
prospectively randomized to receive either orchidopexy alone (21patients) or with neo-adjuvent 
GnRH therapy. Result show that neo-adjuvant administration of GnRH improved the fertility 
index above 0,6 and subsequently improved future individual fertility potential. Recently, a 
prospective study followed boys who underwent  orchidopexy and were subsequently treated 
with a six month course of agonist analogs of LHRH .This group was compared to a control 
group who included only boys treated by orchidopexy alone. Results focus on semen analysis 
(number of sperm per ejaculate), measured in early adulthood. Patients receiving both hormonal 
and orchidopexy had a significantly higher sperm count compared with boys treated with surgery 
alone. This first result could be of future interest to improve fertility potential in cryptorchid 
patients. 
 
6.5 Surgical treatment : 
Surgical treatment of UDT should be performed after sixth months of age if the testes have not 
yet descended by that time. Inguinal or scrotal orchidopexy remains the goldstandard procedure 
to preserve both testicular function and future fertility in male patients. However the type of 
procedure will depend on the precise location of the testes and will differ if the testes are 
palpable or non-palpable. 
 
6.5.1Palpable UDT: 
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Standard inguinal and scrotal incisions are the well-known approach for treatment of 
palpable UDT.(38) Adequate spermatic length should be acquired in order to reposition it back 
into the scrotum. The testis and the cord are dissected up to the inguinal ring that is subsequently 
opened to give adequate exposure if more length is required. This dissection is essentially the 
mobilization of the spermatic vessel and the vas deferens out of the endo-abdominal fascia.  
A pathway is made into the scrotum to ensure that there are no obstructive bands of tissue 
remaining. Scrotal fixation is done by a subcutaneous pouch method with fixation of the testis 
beneath the skin and above the dartos muscle.(39) A path is made between the skin and the 
dartos, the testis are positioned back in the pouch and sutured directly to the dartos muscle. 
A recent series or a single incision approach orchidopexy for low lying UDT showed to 
be as effective as the two wide spread orchidopexy incisions. (40)It can safely be used to 
additionally repair hernias if adequate ligation cannot be achieved, it can be converted to the 
conventional inguinal and scrotal procedure. This new approach presents with enhanced time 
recovery and better cosmetic outcome. 
 
 
6.5.2 Non palpable UDT  
In case of non-palpable testis, laparoscopic exploration of the peritoneum and abdominal 
cavity and subsequent repair should be performed. Laparoscopic techniques have become widely 
used among young surgeons and allow minimally invasive methods for orchidopexy.(41) 
 When direct visualization of intra-abdominal testis is encountered, careful attention 
should be paid to the anatomic vascular structures: spermatic vessels signals surgical end of 
exploration and determinates the next step of surgical repair. If the testicular vasculature is long 
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enough then a primary orchidopexy is performed. In cases where the vasculature is too short for 
adequate testicular mobilization, one-stage or two stage Fowler Stephen (FS) orchidopexy can be 
performed.(42) In one stage FS, direct ligation of the spermatic vessel and repositioning of the 
testis in the scrotum is made in a single fashion, whereas in the two-stage FS, a primary ligation 
is done to allow collateral circulation to develop and a second surgery will be performed sixth 
months later to position the testis in the scrotum. 
The decision for proceeding with one or the other procedure mainly depends on testicular 
position, anatomical structures and the surgeon’s technical skills. 
In any case, testicular biopsy should be performed at the time of orchidopexy for later 
histopathological analysis. Biopsy analysis provides an important tool in assessing future male 
fertility potential and determines the additional benefit for additional hormonal treatment. 
Moreover, in cases where dimorphic testis are found at the time of the orchidopexy, a biopsy will 
help determine the need for orchidectomy instead of orchidopexy, if the patient presents with a 
normal contra-lateral testis. 
 
7.0 FERTILITY ASPECT 
 
Men with a history of cryptorchidism have an increased risk of infertility. The risk is 
even higher when a patient presents with bilateral cryptorchidism. Outcomes related to infertility 
include paternity rates, semen analysis, serum LH levels, FSH and Inhibin B and testicular size. 
(43).Testicular size and sperm density are positively correlated to germ cell status in cryptorchid 
testis in children. At birth, cryptorchid patients harbour germ cells in the testis but in reduced 
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numbers compared to normal boys. Early surgical repair may preserve the neonatal gonocyte 
pool to increase future fertility. 
The mean number of spermatogonia and gonocyte per tubule cross-section (mean S/T) correlates 
positively with sperm count in adulthood. If decreased S/T values are found after biopsy, the risk 
of infertility is high and correlates with the S/T value. In cases where no germ cells are found at 
biopsy, the risk of infertility increases from 78 to 100%. 
Concerning the history of unilateral cryptorchidism, the contralateral testis that undergoes 
normal descent also presents with tissue injuries, and shows decreased numbers of gonocytes 
than in normal testis. (44)Underlying mechanisms leading to infertility in cryptorchid patients 
are multiple and are still not clear. 
Gonadal hyperthermia is recognized as one of the first incriminating factors. To achieve 
their proper exocrine function,the testicles must be maintained at a temperature two degrees 
lower than the core body temperature (ideally between 33 and 35 °C). (45)Hyperthermia induced 
by prolonged abdominal location plays a part in spermatogenesis dysfunction. The hyperthermic 
state leads to a relative increase in the metabolic needs of the gonads that leads to testicular 
hypoxia. This hypoxic state increases production of oxidative molecules that cause irreversible 
damage to the testicular tissue. (46)Stigma of oxidative stress can also be found in the healthy 
testicle of the unilateral cryptorchid patient. 
Thirty-six to 45% of the population with a history of cryptorchidism present with 
congenital anomalies of the seminal canal presenting as secondary atresia of the epididymis or 
testicular cords. (47) The exact mechanism of this phenomenon is still not fully understood and 
also partly gives rise to the fertility etiology in patients with cryptorchidism. 
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Iatrogenic lesions of the testicular and seminal ducts include dissections of testicular 
vessels during orchidopexy that can cause testicular ischemia. Incidence of this complication 
increases with a high testicular position and can range from 8 to 25%. 
In men treated with unilateral orchidopexy a higher rate of testicular arterial anomalies are 
associated with the cryptorchid testis. Moreover, if surgery is performed too early in life, surgical 
orchidopexy can injure the seminal ducts since visualization is more difficult. (48) 
 
The immunologic phenomenon is seen in 30 to 66% of patients with a history of cryptorchidism 
and has antibody anti-spermatozoids in seminal fluid. These antibodies come from spermatozoid 
exposure of the immune system following hemato-testicular barrier rupture during orchidopexy. 
(49) 
 
Histological testicular lesions have been noticed in patients with orchidopexy, these lesions are 
characterized by; (50) 
-diminution of germ cell count 
-diminution of seminiferous tract diameter 
-thickening of the peritubular sheath 
-interstitial tissue fibrosis 
 All these findings combined contribute to the mechanism of infertility in males( 51) 
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8.0 LONG TERM OUTCOME, TESTICULAR CANCER 
 
Patients presenting with a clinical history of UDT are at an increased risk for malignant 
transformation at an older age and long-term follow-up should be performed in those patient 
after puberty. Incidence of malignancy in cryptorchid patients varies from 0,05 to 1%. Self-
examination and education of patients should be taught in order to detect early cancer symptoms 
and provide early management.  Studies have shown that early age orchidopexy decreases therisk 
for malignant transformation.(52,53)  Most testicular cancers comprise a diverse group of 
neoplasms among which germ cell tumor are most commonly found; seminomas is the most 
common type encountered with patients with cryptorchidism and account for 60% of germ cell 
tumors.Patients usually come to clinical attention because of a painless testicular mass or 
increased testicular volume and a decreased libido. Additional symptoms include asthenia, 
anorexia, and weight loss. 
Testicular examination should be bilateral with comparative inspection for intra-testicular 
nodules, persistence of epididymo-testicular creases (Chevassus sign) as infiltration of the 
spermatic cord should be oriented toward a potential malignancy. 
 
Diagnosis: an emergency inguinal orchidectomy must be performed to access positive diagnosis 
and therapeutic options. 
 Further investigation should be carried out to assess metastatic potential using MRI and 
TEP scan. Histologic markers include HCG, LDH, AFP and are of clinical significance for 
diagnosis, prognosis and follow up. 
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Testicular cancer usually presents with a good positive outcome with a total 5-year 
survival rate over 90% as GCT are responsive to both chemotherapy and radiotherapy.Treatment 
options mostly include surgical orchidectomy and adjuvant chemotherapy and radiotherapy 
treatment depending on TNM staging. 
Life-long clinical follow up will be mandatory in order to detect early or late relapse. 
 
 
 
 
9.0 CONCLUSION 
 
Cryptorchidism is a common anomaly that presents as a challenge for the paediatric 
endocrinologist, paediatric urologist and the general pediatrician. Better training and education 
of general practitioners should benefit male patients in the early diagnosis and treatment. 
The lack of understanding of the intrinsic mechanisms involved in the pathogenesis of 
this anomaly can be reviewed in the literature, which provides clear guidelines for diagnosis and 
management of cryptorchidism and provides male patients with a better fertility outcome. 
Despite improvement in functional outcome, cryptorchid patients are still at an increased risk for 
testicular cancer and should be kept under continuous surveillance of the disease. 
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